These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 19168111

  • 1. Efficacy of pneumococcal conjugate vaccine against PCR-positive acute otitis media.
    Palmu AA, Saukkoriipi A, Jokinen J, Leinonen M, Kilpi TM.
    Vaccine; 2009 Mar 04; 27(10):1490-1. PubMed ID: 19168111
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.
    Kilpi T, Ahman H, Jokinen J, Lankinen KS, Palmu A, Savolainen H, Grönholm M, Leinonen M, Hovi T, Eskola J, Käyhty H, Bohidar N, Sadoff JC, Mäkelä PH, Finnish Otitis Media Study Group.
    Clin Infect Dis; 2003 Nov 01; 37(9):1155-64. PubMed ID: 14557958
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines.
    Dagan R, Givon-Lavi N, Shkolnik L, Yagupsky P, Fraser D.
    J Infect Dis; 2000 Apr 01; 181(4):1322-9. PubMed ID: 10753730
    [Abstract] [Full Text] [Related]

  • 8. Impact of different case definitions for acute otitis media on the efficacy estimates of a pneumococcal conjugate vaccine.
    Palmu A, Jokinen J, Kilpi T, Finnish Otitis Media Study Group.
    Vaccine; 2008 May 12; 26(20):2466-70. PubMed ID: 18420315
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
    Pavia M, Bianco A, Nobile CG, Marinelli P, Angelillo IF.
    Pediatrics; 2009 Jun 12; 123(6):e1103-10. PubMed ID: 19482744
    [Abstract] [Full Text] [Related]

  • 10. Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
    Prymula R.
    Vaccine; 2009 Jul 30; 27(35):4739-40. PubMed ID: 19540951
    [Abstract] [Full Text] [Related]

  • 11. [Vaccination against acute otitis media].
    Veenhoven RH, van den Berg YL, Schilder AG, Dhooge IJ, Rijkers GT, Sanders EA.
    Ned Tijdschr Geneeskd; 2000 May 13; 144(20):931-4. PubMed ID: 10827848
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.
    Ekström N, Väkeväinen M, Verho J, Kilpi T, Käyhty H.
    Infect Immun; 2007 Apr 13; 75(4):1794-800. PubMed ID: 17261612
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media.
    Jokinen JT, Ahman H, Kilpi TM, Mäkelä PH, Käyhty MH.
    J Infect Dis; 2004 Aug 01; 190(3):545-50. PubMed ID: 15243930
    [Abstract] [Full Text] [Related]

  • 16. Authors' reply to Prymula R. Re: "Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines" [Vaccine 27 (2009) 4739-4740].
    Rodgers GL, Arguedas A, Cohen R, Dagan R.
    Vaccine; 2009 Sep 04; 27(40):5429-30. PubMed ID: 19643215
    [No Abstract] [Full Text] [Related]

  • 17. The impact of pneumococcal conjugate vaccines on otitis media-can we extrapolate to pneumonia?
    Dagan R.
    Vaccine; 2008 Jun 16; 26 Suppl 2():B16-8. PubMed ID: 18793601
    [Abstract] [Full Text] [Related]

  • 18. Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era.
    Pichichero ME, Casey JR.
    Pediatr Infect Dis J; 2007 Oct 16; 26(10 Suppl):S12-6. PubMed ID: 18049375
    [Abstract] [Full Text] [Related]

  • 19. Association of clinical signs and symptoms with pneumococcal acute otitis media by serotype--implications for vaccine effect.
    Palmu AA, Jokinen JT, Kaijalainen T, Leinonen M, Karma P, Kilpi TM.
    Clin Infect Dis; 2005 Jan 01; 40(1):52-7. PubMed ID: 15614692
    [Abstract] [Full Text] [Related]

  • 20. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
    Rodgers GL, Arguedas A, Cohen R, Dagan R.
    Vaccine; 2009 Jun 12; 27(29):3802-10. PubMed ID: 19446378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.